Developments In Iranian Health Care Sector

3 September 1995

Little is really known about health care and the pharmaceutical industry in Iran, but several recent IRNA news agency announcements have shed some light on developments there. The following are summaries of these items:

- The Razi Research Center in Iran's Mazandaran province is currently producing 2 billion doses of vaccines and serums each year, saving Iran some $60 million in imports. The center produces 23 types of vaccines and four kinds of serums for the treatment of poisoning, as well as other medicines.

- Iranian and Georgian officials signed an agreement for bilateral cooperation in the chemical and pharmaceutical industries during a recent visit of Iranian President Rafsanjani to Tbilisi, the Georgian capital. It was also mentioned that Georgia may use Iranian transit facilities for its exports and imports;

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight